JPET Assistant Professor of Medicine (Clinician-Educator)

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by STEINBERG, M. I.
Right arrow Articles by SMITH, C. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by STEINBERG, M. I.
Right arrow Articles by SMITH, C. B.
Journal of Pharmacology And Experimental Therapeutics, Vol. 173, Issue 1, 176-192, 1970
Copyright © 1970 by American Society for Pharmacology and Experimental Therapeutics


EFFECTS OF DESMETHYLIMIPRAMINE AND COCAINE ON THE UPTAKE, RETENTION AND METABOLISM OF H3-TYRAMINE IN RAT BRAiN SLICES

M. I. STEINBERG 1 and C. B. SMITH 1

1 Department of Pharmacology, University of Michigan Medical School, Ann Arbor, Michigan

Slices of hypothalamus, brainstem, parietal cortex and caudate from rat brain were incubated in Krebs-Ringer solution at 37°C for 20 minutes with H3- tyramine (1.4 x 10-7 M). Slices from all areas synthesized H3-p-hydroxyphenylacetic acid (H3-p-HPAA) and H3-octopamine. In addition, some of the H3-tyramine which was taken up was retained unmetabolized. Although caudate slices made less H3-octopamine, these slices made more H3-p-HPAA and retained much more H3-tyramine than slices from the other areas. Neither H3-octopamine nor H3-p-hydroxymande1ic acid was found in bathing solutions or washes of slices from any area. Cocaine (10-6-3 x 10-4 M), when added to the incubation flask 15 minutes before the addition of H3-tyramine, caused a decrease in both H3-octopamine and H3-p-HPAA synthesis as well as a decrease in the amount of H3- tyramine retained. In contrast, desmethylimipramine (DMI, 10-7 and 10-6 M), when added to the incubation flask 15 minutes before the H3-tyramine, caused a marked decrease in the synthesis of H3-octopamine but did not decrease the synthesis of H3-p-HPAA or diminish the retention of H3-tyramine. Similar results were obtained with slices from rats pretreated with DMI (2-60 mg/kg, i.p.) one hour before sacrifice. The inhibition of H3-octopamine synthesis caused by DMI, both in vivo and in vitro, was noncompetitive, whereas that produced by cocaine was competitive. Cocaine (10-4 M) and DMI (60 mg/ kg and 10-6 M), when added to homogenates of hypothalamus, had no effect on the synthesis of either H3-p-hydroxymandelic acid or 3-p-HPAA. These results indicate that cocaine blocks the uptake of H3-tyramine at the neuronal membrane. In contrast, low doses of DMI do not prevent the uptake of H3-tyramine at the neuronal membrane and subsequent synthesis of H3-p-HPAA, but do prevent the uptake of H3-tyramine into the intraneuronal sites where it is converted into H3-octopamine.

Submitted on June 5, 1969
Accepted on January 17, 1970




This article has been cited by other articles:


Home page
J. Neurosci.Home page
M. S. Sonders, S.-J. Zhu, N. R. Zahniser, M. P. Kavanaugh, and S. G. Amara
Multiple Ionic Conductances of the Human Dopamine Transporter: The Actions of Dopamine and Psychostimulants
J. Neurosci., February 1, 1997; 17(3): 960 - 974.
[Abstract] [Full Text] [PDF]


Home page
ScienceHome page
F. Crews and C. Smith
Presynaptic alpha-receptor subsensitivity after long-term antidepressant treatment
Science, October 20, 1978; 202(4365): 322 - 324.
[Abstract] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1970 by the American Society for Pharmacology and Experimental Therapeutics.